Aug 9, 2021 The companies have signed orders of more than 2.2 billion doses for delivery in 2021 and more than one billion doses for 2022 and beyond as of July 21, 2021. Further … From investors.biontech.de
Nov 2, 2021 The Comirnaty (1) revenue projection incorporated within Pfizer’s 2021 financial guidance includes approximately 2.3 billion doses that are expected to be delivered in fiscal … From pfizer.com
Mar 30, 2022 1 BioNTech’s profit share is estimated based on preliminary data shared between Pfizer and BioNTech as further described in the Annual Report on Form 20-F for the year … From investors.biontech.de
MAINZ, GERMANY, March 16, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth … From investors.biontech.de
PFIZER MRNA PARTNER BIONTECH REAPED €19B LAST YEAR BUT WARNS …
Mar 30, 2022 Thanks to the vaccine launch, BioNTech posted a mong boggling 38-fold sales increase year-over-year. BioNTech and Pfizer delivered 2.6 billion doses of their vaccine in … From fiercepharma.com
The Investor Relations website contains information about BioNTech's business for stockholders, potential investors, and financial analysts. From investors.biontech.de
Nov 9, 2021 Delivered more than 2 billion doses of COMIRNATY/BNT162b2 in 2021 as of November 2 nd Demonstrated progress in expanding access to COVID-19 vaccine globally, … From investors.biontech.de
BIONTECH ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS AND …
In March 2021, BioNTech announced its Full Year 2020 Financial Results and Corporate Update as a part of the Annual Report filed on Form 20-F, highlighting developments relating to its … From investors.biontech.de
2022-03-30 | NDAQ:BNTX | PRESS RELEASE | BIONTECH SE
Mar 30, 2022 Approximately 2.6 billion doses of COMIRNATY®/BNT162b2 delivered to more than 165 countries and regions worldwide in 2021, including more than 1 billion doses to … From stockhouse.com
BIONTECH POSTS TRIPLED Q1 VACCINE SALES BUT STILL FLAGS ... - 商业时报
May 9, 2022 BioNTech reiterated its 2022 vaccine revenue guidance of between 13 billion and 17 billion euros, down from 19 billion last year, implying a decline during the rest of the year. … From businesstimes.com.sg
BIONTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 …
Mar 30, 2022 Approximately 2.6 billion doses of COMIRNATY®/BNT162b2 delivered to more than 165 countries and regions worldwide in 2021, including more than 1 billion doses to low- … From kfor.com
Mar 30, 2022 Approximately 2.6 billion doses of Comirnaty/BNT162b2 were delivered to more than 165 countries and regions worldwide in 2021, including more than 1 billion doses to low- … From thepharmaletter.com
BIONTECH PROFITS SOAR IN 2021 ON GLOBAL VACCINE ROLLOUT
The company delivered 2.6 billion doses of the vaccine based on mRNA technology in 2021, pulling in revenues of 19 billion euros in the process. From medicalxpress.com
BIONTECH SLASHES 2023 REVENUE PROJECTION FROM €5B TO €4B
Nov 6, 2023 BioNTech has slashed its estimate of 2023 revenue by 20%, now expecting it to reach 4B euros versus its previous estimate of 5B euros. From fiercepharma.com
BIONTECH PROFITS SOAR IN 2021 ON GLOBAL VACCINE ROLLOUT
The company delivered 2.6 billion doses of the vaccine based on mRNA technology in 2021, pulling in revenues of 19 billion euros in the process. BioNTech projects vaccine revenues in … From expatica.com
May 9, 2022 On March 30, 2022, BioNTech announced its Full Year 2021 Financial Results and Corporate Update as a part of the Annual Report filed on Form 20-F, also highlighting … From investors.biontech.de
MAJOR COVID-19 VACCINES SALES FORECAST WORLDWIDE 2021-2022| STATISTA
Aug 29, 2023 In 2021, COVID-19 vaccine Comirnaty produced by Biontech and Pfizer is expected to make 36 billion U.S. dollars in sales worldwide, while Moderna's mRNA-1273 … From statista.com
BIONTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 …
Mar 20, 2024 Conference call and webcast scheduled for March 20, 2024, at 8:00 a.m. ET (1:00 p.m. CET) MAINZ, Germany, March 20, 2024 (GLOBE NEWSWIRE) -- BioNTech SE … From investors.biontech.de
BIONTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 …
Mar 30, 2022 Conference call and webcast scheduled for March 30, 2022 at 8:00 am ET (2:00 pm CET) MAINZ, Germany, March 30, 2022 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: … From investors.biontech.de
Are you curently on diet or you just want to control your food's nutritions, ingredients? We will help you find recipes by cooking method, nutrition, ingredients...
